Clinical Trial Update: Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oral ketamine for depression and anxiety in cancer patients; the study was terminated and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety
• Cancer
• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Mayo Clinic | Conditions: Cancer, Depression | Phase 2 | Status: TERMINATED | Results posted: 2016-02-29